European Journal of Pediatrics

, Volume 151, Issue 9, pp 688–692 | Cite as

Complement fragment C3a in plasma of asphyxiated neonates

  • L. Schrod
  • G. Frauendienst-Egger
  • H. B. von Stockhausen
  • M. Kirschfink
Neonatology

Abstract

Recent clinical studies with adult polytrauma patients indicate that elevated plasma levels of anaphylatoxin C3a correlate with the subsequent development of the adult respiratory distress syndrome (ARDS). However, there are no parameters which allow a reliable diagnosis of ARDS in neonates. As the most predisposing condition for ARDS seems to be shock, plasma C3a was determined in 30 ventilated premature infants and neonates with respiratory distress syndrome (birth weights 660–3350 g) within the first 24 h post partum or 6–24 h after acute asphyxia or shock during the neonatal period. The range of C3a, measured by ELISA, was between 57 and 1000 ng/ml. In the asphyxia group (n=15) peak levels of C3a in plasma (mean 388 ng/ml) were significantly higher (P<0.001) than in the control group (mean 153 ng/ml). In some neonates with suspected ARDS, additional samples were taken. A rise in C3a between days 2 and 8 was associated with a fatal outcome of the disease. As in adults, C3a might be a useful indicator for ARDS in neonates.

Key words

Neonates Complement Anaphylatoxin C3a ARDS 

Abbreviations

ARDS

adult or acquired respiratory distress syndrome

IRDS

idiopathic or infantile respiratory distress syndrome

RDS

respiratory distress syndrome

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bland RD (1987) Pathogenesis of pulmonary edema after premature birth. Adv Pediatr 34:175–222PubMedGoogle Scholar
  2. 2.
    Borelli E, Giomerelli P, Chiari O, Casini A, Betti S, Sabatini L, Lorenzini L, Grossi A (1990) Lipid peroxidation and lung ultrastructural changes in an experimental model of leukocytemediated pulmonary injury. Lung 168:35–42Google Scholar
  3. 3.
    Burger R, Zilow G, Bader A, Friedlein A, Naser W (1988) The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential. J Immunol 141:553–558PubMedGoogle Scholar
  4. 4.
    Drew JH, Arroyave CM (1980) The complement system of the newborn infant. Biol Neonate 37:209–217PubMedGoogle Scholar
  5. 5.
    Faix RG, Viscardi RM, DiPietro MA, Nicks JJ (1989) Adult respiratory distress syndrome in full-term newborns. Pediatrics 83:971–976PubMedGoogle Scholar
  6. 6.
    Feinstein PA, Kaplan SR (1975) The alternative pathway of complement activation in the neonate. Pediatr Res 9:803–806PubMedGoogle Scholar
  7. 7.
    Giedion A, Haeflinger H, Dangel P (1973) Acute pulmonary x-ray changes in hyaline membrane disease treated with artificial ventilation and positive endexpiratory pressure. Pediatr Radiol 1:145–149PubMedGoogle Scholar
  8. 8.
    Guillois B, Berthou C, Awad H, Bendaoud B, Guillemin G, Alix D, Youinou P (1989) The importance of C3d estimation in the diagnosis of generalized bacterial infections in the newborn infants. Acta Paediatr Scand 78:369–372PubMedGoogle Scholar
  9. 9.
    Hack CE, Nuijens JH, Felt-Bersma RJ, Schreuder WO, Eerenberg-Belmer AJ, Paardekooper J, Bronsveld W, Thijs LG (1989) Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med 86:20–26PubMedGoogle Scholar
  10. 10.
    Hammerschmidt DE, Weaver LJ, Hudson LD, Craddock PR, Jacob HS (1980) Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Lancet I:947–949Google Scholar
  11. 11.
    Hohn DC, Meyers AJ, Gherini ST, Beckmann A, Markison RE, Churg AM (1980) Production of acute pulmonary injury by leukocytes and activated complement. Surgery 88:48–58PubMedGoogle Scholar
  12. 12.
    Johnston RB, Altenburger KM, Atkinson AW, Curry RH (1979) Complement in the newborn infant. Pediatrics 64 [Suppl]: 781–786PubMedGoogle Scholar
  13. 13.
    Killermann W, Frentzel-Beyme R, Welte M, Jochum M (1989) Phospholipase A2 in acute lung injury after trauma and sepsis: its relation to the inflammatory mediators PMN-elastase, C3a and neopterin. Klin Wochenschr 67:190–195PubMedGoogle Scholar
  14. 14.
    Kitajima H, Fujimura M, Takeuchi T, Miyano A, Nakayama M, Fujita T, Imai S, Shimizu A (1990) Effect of amnionitis on the complement system of premature infants. Early Hum Dev 21:59–69PubMedGoogle Scholar
  15. 15.
    Lambris JD (1988) The multifunctional role of C3, the third component of complement. Immunol Today 9:387–393PubMedGoogle Scholar
  16. 16.
    Langlois PF, Gawryl MS, Zeller J, Lint T (1989) Accentuated complement activation in patient plasma during the adult respiratory distress syndrome: a potential mechanism for pulmonary inflammation. Heart Lung 18:71–84PubMedGoogle Scholar
  17. 17.
    Lundberg C, Gardinali M, Hugli TE (1987) Complement activation and membrane lipids in lung vascular injury. Am Rev Respir Dis 136:459–462bPubMedGoogle Scholar
  18. 18.
    Lyrene RK, Truog WE (1981) Adult respiratory distress syndrome in a pediatric intensive care unit: predisposing conditions, clinical course, and outcome. Pediatrics 67:790–795PubMedGoogle Scholar
  19. 19.
    Matthay M, Eschenbacher W, Goetzel E (1984) Elevated concentrations of leukotriene B4 in the pulmonary edema fluid of patients with adult respiratory distress syndrome. J Clin Immunol 4:479–483PubMedGoogle Scholar
  20. 20.
    Modig J, Samuelsson T, Hallgren R (1986) The predictive and discriminative value of biologically active products of eosinophils, neutrophils and complement in bronchoalveolar lavage and blood in patients with adult respiratory distress syndrome. Resuscitation 14:121–134PubMedGoogle Scholar
  21. 21.
    Notarangelo LD, Chirico G, Chiara A, Colombo A, Rondini G, Plebani A, Martini A, Ugazio AG (1984) Activity of classical and alternative pathways of complement in preterm and small for gestational age infants. Pediatr Res 18:281–285PubMedGoogle Scholar
  22. 22.
    Parson PE, Worthen GS, Moore EE, Tate RM, Henson PM (1989) The association of circulating endotoxin with the development of the adult respiratory distress syndrome. Am Rev Respir Dis 140:294–301PubMedGoogle Scholar
  23. 23.
    Pfenninger J, Gerber A, Tschäppeler H, Zimmermann A (1982) Adult respiratory distress syndrome in children. J Pediatr 101:352–357PubMedGoogle Scholar
  24. 24.
    Rinaldo JE, Rogers RM (1986) Adult respiratory distress syndrome. N Engl J Med 315:578–579PubMedGoogle Scholar
  25. 25.
    Royall JA, Levin DL (1988) Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury. J Pediatr 112: 169–180PubMedGoogle Scholar
  26. 26.
    Sawyer MK, Forman ML, Kuplic LS, Stiehm ER (1971) Development aspects of the human complement system. Biol Neonate 19:148–162PubMedGoogle Scholar
  27. 27.
    Shapiro R, Beatty DW, Woods DL, Malan AF, Med M (1981) Serum complement and immunoglobulin values in small-for-gestational-age infants. J Pediatr 99:139–141PubMedGoogle Scholar
  28. 28.
    Slotman GJ, Burchard KW, Yellin SA, Williams JJ (1986) Prostaglandin and complement interaction in clinical acute respiratory failure. Arch Surg 121:271–274PubMedGoogle Scholar
  29. 29.
    Strunk RC, Fenton LJ, Gaines JA (1979) Alternative pathway of complement activation in full term and premature infants. Pediatr Res 13:641–643PubMedGoogle Scholar
  30. 30.
    Thibeault DW, Hall FK, Sheehan MB, et al. (1984) Postasphyxial lung disease in newborn infants with severe perinatal acidosis. Am J Obstet Gynecol 150:393–399PubMedGoogle Scholar
  31. 31.
    Truog WE, Gibson RL, Henderson WR, Redding GJ (1990) Tumor necrosis factor-induced neonatal pulmonary hypertension: effects of Dazmegrel pretreatment. Pediatr Res 27:466–471PubMedGoogle Scholar
  32. 32.
    Weigelt JA, Chenoweth DE, Borman KR, Norcross JF (1988) Complement and the severity of pulmonary failure. J Trauma 28:1013–1019PubMedGoogle Scholar
  33. 33.
    Weinberg PF, Matthay MA, Webster RO, Roskos KV, Goldstein IM, Murray JF (1984) Biologically active products of complement and acute lung injury in patients with sepsis syndrome. Am Rev Respir Dis 130:791–796PubMedGoogle Scholar
  34. 34.
    Zilow G, Sturm JA, Rother U, Kirschfink M (1990) Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome. Clin Exp Immunol 79:151–157PubMedGoogle Scholar
  35. 35.
    Zilow G, Burger R, Stuthe M, Zilow EP (1990) Increased C3a-des Arg concentration as indicator for neonatal infections. Immunobiology 181:250(A)Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • L. Schrod
    • 1
  • G. Frauendienst-Egger
    • 1
  • H. B. von Stockhausen
    • 1
  • M. Kirschfink
    • 2
  1. 1.Department of PaediatricsUniversity of WürzburgWürzburgGermany
  2. 2.Institute for ImmunologyUniversity of HeidelbergHeidelbergGermany

Personalised recommendations